Intestinal Crosstalk between Microbiota and Serotonin and its Impact on Gut Motility

Curr Pharm Biotechnol. 2018;19(3):190-195. doi: 10.2174/1389201019666180528094202.

Abstract

Background: The gastrointestinal tract harbours a diverse bacterial community that contributes to health and disease. A number of studies have demonstrated that the gut microbiota plays a critical role in the metabolism of serotonin.

Methods: Microbial-derived metabolites, such as bile acids and short-chain fatty acids, are reported to affect the production of serotonin which, in turn, directly or indirectly regulates gut motility. Enterochromaffin cells are important specialized endocrine cells found in the intestine, which is the major location of serotonin biosynthesis. The relationship between microbiota and gut motility are studied depended on microbial-derived metabolites and serotonin.

Results and conclusion: Both bile acids and short-chain fatty acids can modulate serotonin metabolism in hosts by affecting key intermediates of the serotonin pathway. Thus, gut motility may be regulated through microbial modifications of host serotonin biosynthesis, which continues to be evaluated as a target for functional gastrointestinal disorders.

Keywords: Intestinal microbiota; bile acids; endocrine cells; gut motility; serotonin; short chain fatty acids..

Publication types

  • Review

MeSH terms

  • Animals
  • Bile Acids and Salts / metabolism
  • Fatty Acids / metabolism
  • Gastrointestinal Microbiome*
  • Gastrointestinal Motility*
  • Gastrointestinal Tract / metabolism
  • Gastrointestinal Tract / microbiology
  • Gastrointestinal Tract / physiology*
  • Humans
  • Serotonin / metabolism
  • Serotonin / physiology*

Substances

  • Bile Acids and Salts
  • Fatty Acids
  • Serotonin